Tamoxifen Completed Phase 3 Trials for Fallopian Tube Cancer / Recurrent Ovarian Epithelial Cancer / Primary Peritoneal Cavity Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00041080Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer